AMANDA JOLIET: Open Payments
NPI 1497519607 · CLEVELAND, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$776 in 39 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $357 · 2025 $776
Food & beverage: $776
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $175 |
| AstraZeneca Pharmaceuticals LP | 7 | $143 |
| ABBVIE INC. | 5 | $104 |
| Inspire Medical Systems, Inc. | 2 | $51 |
| Exact Sciences Corporation | 3 | $44 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $42 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $40 |
| Medtronic, Inc. | 2 | $35 |
| Verona Pharma, Inc. | 1 | $25 |
| Lilly USA, LLC | 1 | $22 |
Products named: QULIPTA, AIRSUPRA, Wegovy, JARDIANCE, Ozempic, FARXIGA, Rybelsus, INSPIRE.
Industry payments across TN — which companies pay providers there.
